Argus Investors' Counsel, Inc. Integra Lifesciences Holdings Corp Transaction History

Argus Investors' Counsel, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 16, 2019	SELL	$42.97 - $57.33 $231,436 - $308,779	-5,386 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$42.62 - $64.51 $35,758 - $54,123	839 Added 18.45%	5,386 $243,000
Q3 2018 Oct 16, 2018	BUY	$57.63 - $65.87 $262,043 - $299,510	4,547 New	4,547 $0

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.